Holding(s) in Company

RNS Number : 8440D

BlueCrest AllBlue Fund Ltd

09 December 2009

 



For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				BlueCrest AllBlue Fund Limited
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	Please refer to Sec.13				Yes
3. Full name of person(s) subject to the notification obligation: iii		Barclays Plc
4. Full name of shareholder(s)   (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v		01/12/2009
6. Date on which issuer notified:		03/12/2009
7. Threshold(s) that is/are crossed or reached: vi, vii		6 & 5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B13YVW48 GB00B13YXH37 GB00B13YXC81

12,212,359 2,257,204 290,380

12,212,359 2,257,204 290,380

Not reportable

Not reportable

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/  Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Not reportable

Not reportable

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	On 1 December 2009, Barclays Group sold the Barclays Global Investors business, including Barclays Global Investors Ltd, Barclays Global Investors (Deutschland) Ltd, Barclays Global Investors N.A. and Barclays Global Fund Advisors to BlackRock Inc. Accordingly, holdings of Barclays Global Investors Ltd, Barclays Global Investors (Deutschland) Ltd, Barclays Global Investors N.A. and Barclays Global Fund Advisors are no longer attributable to the Barclays Group/Barclays plc and responsibility for making relevant shareholding disclosures relating to holdings of Barclays Global Investors Ltd, Barclays Global Investors (Deutschland) Ltd, Barclays Global Investors N.A. and Barclays Global Fund Advisors and other entities in the Barclays Global Investors business now lies with BlackRock.
14. Contact name:	James Gibson
15. Contact telephone number:	020 7116 7308

Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in share
A: Identity of the persons or legal entity subject to the notification obligation
Full name  (including legal form of legal entities)	Barclays plc
Contact address  (registered office for legal entities)	Level 29, 1 Churchill Place London E14 5HP
Phone number & email	0207 116 7308
Other useful information  (at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.

 

END

 

 

HOLTLBTTMMTMBAL